A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Zheng, Hong, Mineishi, Shin, Claxton, David, Zhu, Junjia, Zhao, Chenchen, Jia, Bei, Ehmann, W. Christopher, Rybka, Witold B., Naik, Seema, Songdej, Natthapol, Drabick, Joseph J., Hohl, Raymond J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Correspondences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894154/
https://www.ncbi.nlm.nih.gov/pubmed/33146922
http://dx.doi.org/10.1002/ajh.26043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894154/
https://www.ncbi.nlm.nih.gov/pubmed/33146922
http://dx.doi.org/10.1002/ajh.26043

Ejemplares similares